Company intelligence / Profile preview

Nika Pharmaceuticals

Henderson, Nevada, United Statesnikapharmaceuticals.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Nika Pharmaceuticals has developed a portfolio including six injectable drugs—two of which have successfully undergone clinical trials with positive treatment outcomes—as well as four tablet-form drugs and eleven dietary supplements. Its lead program, ITV‑1, has shown curative effects in volunteers suffering from AIDS and cancer beyond formal trial statistics. The company is expanding manufacturing capabilities for broader distribution

Therapeutic areas: OncologyEndocrinologyImmunologyInfectious Diseases
Modalities: Small moleculeProtein
Industry: Biotech

Drug pipeline

3 assets

TNG

Unknown

2 more assets in the full pipeline.

Request access →

Partnerships

Immunotech Laboratories BGDistribution partners in Nigeria, Ukraine, UAE, Iraq, Jordan, Syria for ITV‑1 product lines

Beyond the preview

Go deeper on Nika Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nika Pharmaceuticals.

Explore the full profile